Study Suggests Rapamycin May Extend Women’s Fertility and Promote Healthier Aging

A groundbreaking study suggests that the immunosuppressant rapamycin could extend women’s fertility by up to five years while promoting healthier aging. Co-led by experts at Columbia University, the Vibrant study aims to slow ovarian aging and delay menopause, potentially revolutionizing women’s reproductive health. Early findings indicate a 20% decrease in ovarian aging with minimal side effects, offering hope for women facing age-related fertility challenges. As participant enrollment continues, this research could change the landscape of women’s health.